Newron News
Most Popular Newron Story
Safinamide shows promising Ph3 results against dyskinesia
Merck Serono and Newron Pharmaceuticals may have a promising new add-on treatment for Parkinson's disease sufferers. According to data from an extension of a previous Phase III trial, the company's Read more...
Latest Headlines
- October 21, 2011
- September 27, 2011
- November 4, 2010
- December 23, 2008
- December 3, 2008
- February 11, 2008
- August 22, 2007
- July 1, 2007
- December 7, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
